Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of STSP-0902 injection in men with oligozoospermia and/or asthenozoospermia
CTR20263471Phase 2Active
- Sponsor
- Staidson Biopharmaceutical
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of STSP-0902 in oligospermia, asthenospermia, sponsored by Staidson Biopharmaceutical. Started Sep 2026; status: active.
02
Drugs
STSP-0902
03
Conditions
oligospermiaasthenospermia
Beyond the preview
Go deeper on CTR20263471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263471.